SignalFDA/Bio

REVOLUTION'S LIFESAVING PANCREATIC CANCER DRUG WINS SPEEDY FDA APPROVAL - REUTERS - GNEWS

FDA approval for targeted pancreatic cancer drug marks major regulatory catalyst.

What changed

FDA approval for targeted pancreatic cancer drug marks major regulatory catalyst.

Why it matters

FDA approval for targeted pancreatic cancer drug marks major regulatory catalyst. — impact context not separately stored; see What changed.

Sources